Table 4.

Means and Standard Deviations (in Parentheses) for Main Study Outcomes (With A Significant Group by Gender Interaction) for Women and Men Separately Across Baseline and at 1-, 6-, and 12-Month Follow-Ups

Outcome	Baseline	1 month	6 month	12 month
Women
PTSDTOT
Treatment	25.31 (25.93)	17.67 (19.75)	15.77 (20.23)	16.57 (17.33)
Control	26.98 (22.98)	25.65 (23.22)	20.83 (23.30)	22.32 (26.35)
HAM–D
Treatment	9.56 (7.63)	6.88 (5.11)	6.56 (5.40)	7.08 (5.83)
Control	9.92 (6.14)	9.00 (7.22)	9.61 (6.68)	8.05 (5.82)
HIV symptoms
Treatment	0.27 (0.45)	0.27 (0.45)	0.13 (0.34)	0.21 (0.41)
Control	0.31 (0.47)	0.30 (0.47)	0.39 (0.49)	0.39 (0.50)
Sample sizea
Treatment	48b	43d	41e	38
Control	47c	46	41	40f
Men
PTSDTOT
Treatment	29.28 (22.38)	22.72 (26.12)	19.13 (20.12)	19.39 (22.86)
Control	29.69 (23.86)	22.50 (20.93)	19.09 (20.67)	14.41 (18.31)
HAM–D
Treatment	9.64 (5.44)	9.50 (6.81)	9.31 (6.97)	7.93 (6.62)
Control	10.58 (7.25)	8.98 (7.36)	7.33 (6.43)	6.34 (5.29)
HIV symptoms
Treatment	0.23 (0.43)	0.21 (0.41)	0.25 (0.43)	.23 (.43)
Control	0.15 (0.36)	0.21 (0.41)	0.18 (0.39)	.16 (.37)
Sample sizea
Treatment	72g	61i	53j	44k
Control	75h	62	55	51l

Note. PTSDTOT = Davidson PTSD (Posttraumatic Stress Disorder) Scale; HAM–D = Hamilton Depression Scale; HIV symptoms = HIV symptom checklist.

^aSample size is for PTSDTOT. For other variables, the sample size is as follows:

^bHAM–D (N = 45);

^cHAM–D (N = 48) and HIV symptoms (N = 48);

^dHIV symptoms (N = 44);

^eHIV symptoms (N = 40);

^fHAM–D (N = 39) and HIV symptoms (N = 38);

^gHAM–D (N = 70);

^hHAM-D (N = 74);

ⁱHAM–D (N = 60);

^jHAM–D (N = 54);

^kHIV symptoms (N = 43);

^lHAM–D and HIV symptoms (N = 50).